President & Founder, Ozmosi
Beau Bush brings to every client a rich background in predictive analytics, risk assessments, and valuation models for the pharmaceutical industry. He has more than 15 years of experience in developing data-based business and investment strategies, including extensive experience preparing and delivering senior-level summaries and recommendations for global investment and growth strategies.
With newly emerging business models and increasing complexity in drug development making it more and more difficult to predict the impact of new products—or decide which products to pursue—Beau envisioned a company that could bring clarity and confidence to the investment decisions that shape tomorrow’s pharmaceutical products.
Beau has a BS in biology from Rutgers University and has worked in several industries, including finance, pharmaceuticals, marine biology, environmental science, and business consulting.
He brings to Ozmosi a deep understanding and broad knowledge of global market valuation and healthcare product development, as well as an extensive network of industry experts.